- Home
- IKT vs FSP Comparison
IKT vs FSP Comparison
Compare IKT & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- FSP
- Stock Information
- Founded
- IKT 2008
- FSP 1981
- Country
- IKT United States
- FSP United States
- Employees
- IKT N/A
- FSP N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- FSP Real Estate Investment Trusts
- Sector
- IKT Health Care
- FSP Real Estate
- Exchange
- IKT Nasdaq
- FSP Nasdaq
- Market Cap
- IKT 159.2M
- FSP 187.5M
- IPO Year
- IKT 2020
- FSP N/A
- Fundamental
- Price
- IKT $2.27
- FSP $1.79
- Analyst Decision
- IKT Strong Buy
- FSP
- Analyst Count
- IKT 2
- FSP 0
- Target Price
- IKT $6.50
- FSP N/A
- AVG Volume (30 Days)
- IKT 194.9K
- FSP 229.5K
- Earning Date
- IKT 03-26-2025
- FSP 02-24-2025
- Dividend Yield
- IKT N/A
- FSP 2.26%
- EPS Growth
- IKT N/A
- FSP N/A
- EPS
- IKT N/A
- FSP N/A
- Revenue
- IKT $1.00
- FSP $126,508,000.00
- Revenue This Year
- IKT N/A
- FSP N/A
- Revenue Next Year
- IKT N/A
- FSP $0.02
- P/E Ratio
- IKT N/A
- FSP N/A
- Revenue Growth
- IKT N/A
- FSP N/A
- 52 Week Low
- IKT $1.12
- FSP $1.47
- 52 Week High
- IKT $4.20
- FSP $2.47
- Technical
- Relative Strength Index (RSI)
- IKT 38.70
- FSP 46.08
- Support Level
- IKT $1.90
- FSP $1.75
- Resistance Level
- IKT $2.37
- FSP $1.88
- Average True Range (ATR)
- IKT 0.25
- FSP 0.06
- MACD
- IKT -0.07
- FSP -0.00
- Stochastic Oscillator
- IKT 34.91
- FSP 26.13
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.